Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002240127 | SCV002511946 | uncertain significance | not specified | 2022-04-24 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003138116 | SCV003819137 | uncertain significance | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734479 | SCV005347789 | uncertain significance | TTN-related disorder | 2024-04-17 | no assertion criteria provided | clinical testing | The TTN c.35185G>A variant is predicted to result in the amino acid substitution p.Glu11729Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.016% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |